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Sudden Cardiac death (SCD) is a major clinical event causing adverse impact on global
economy. This review summarizes the available epidemiological data on SCD from
different parts of the world. It contrasts the Indian and global perception on the issues
influencing data collection, burden of SCD and sudden deaths occurring following
Myocardial Infarction. The differences in data from India and rest of the world are
highlighted.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction
Sudden Cardiac Death (SCD) is a catastrophic event, which
has a huge adverse impact on the health care system. The
ubiquitous distribution of this clinical syndrome mandates it
being recognized as a worldwide phenomenon with the real-
ization that a rising incidence negatively affects global econ-
omy. There is an evident geographical imbalance in the
currently available statistical figures on the global burden of
SCD as practically almost entire published literature in this
area is from North America, Western Europe and few coun-
tries of the Asia pacific. This fact assumes significance as the
perception of the practicing clinician towards this problem
and prioritizing of health care resources in the community are
invariably influenced by this data. In this review, I would like
to present an overview of data collection tools, the global
burden of sudden death, the epidemiology of post Myocardial2013, Cardiological SocieInfarction (MI) SCD and would make an attempt to contrast
the global and Indian perception on issues related to these
areas.2. Data collection tools
Compiling accurate data of SCD even when a standard defi-
nition is used is a challenging task as categorizing a death as
sudden is mostly retrospective and clarity of the circum-
stances leading to the terminal event is often lacking. Ideally
long-term population based prospective mortality surveil-
lance methods should be employed to obtain reliable statis-
tical data, however these are difficult to conduct and hence
different methodologies have been used to obtain the
currently available epidemiological figures. Death certificates
are commonly used for SCD surveillance as they provide
objective documented mortality information. They arety of India. All rights reserved.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) s 1 8es 2 3 S19particularly useful in generating uniform data when standard
disease codes are used. The accuracy of information however
depends on the physician completing the document. The time
interval between onset of symptoms and death is not recorded
and often deaths occurring after prolonged chronic pathol-
ogies are misclassified as SCD. They thus suffer from several
flaws and hence SCD statistics relying solely on retrospective
death certificates are likely to be an overestimate.1 To improve
reliability of data, information fromother sources like hospital
records, forensic documents and questionnaires are used to
supplement facts obtained from death certificates.2,3 Data
obtained from first responders is useful as onsite information
can be obtained, but unwitnessed deaths are missed and in
absence of detailed clinical records, non-cardiac deaths are
sometimes counted amongst SCD cases. Autopsy data is a
meager resource of information as in general autopsy rates
are low and moreover it alone cannot conclusively diagnose
an arrhythmic death. To overcome the limitations of each of
these methodologies, a multiple source method of ascertain-
ment has been used in a few studies in order to capture all the
SCD cases.4,5 While initial recruitment of cases was achieved
by emergency medical personnel, medical examiner, or hos-
pitals, information obtained from medical records, death
certificates and autopsy was also used for analyzing data. It is
increasingly realized that these proven conventional tools
used in developing countries may not be feasible or reliable in
collecting mortality data from developing countries. Verbal
autopsy has evolved as a new tool to circumvent the epide-
miological constraints prevalent in these countries. ThoughTable 1 e The figures of Sudden Cardiac Death obtained from
These are variously expressed as incidence, prevalence or pro
Country Year Population
studied (n ¼)
Population
characteristics
USA11 2001 719,456 Deceased US residents ag
35 years, with underlyi
cardiac disease
USA1 2004 6, 60,486 Multnomah county
residents
France3 1999 7079 Male workers aged 43e52
years followed up for a
mean of 23 years
Netherlands12 1997 133000 SCD cases in the age gro
20e75 years over a period
3 years (1991e1994)
Ireland5 2008 414,277 Population in 3 counties
west of Ireland in the ye
2005
Japan14 2013 1934 Subjects in Hisayama tow
aged >25 years from 196
e2009
China15 2009 678,718 Prospective study of 4
regions for 1 year
India19 2012 22,724 Kindreds of medical
students in the state of
Andhra Pradesh who die
due to any cause
Thailand33 1993 316,931 20e49 years from 401
villages in 4 districts who
died suddenly in the yea
1990initially developed as a tool to be used in acquiring data on
child andmaternal deaths, it has subsequently been validated
as a reliable mortality surveillance system in other age groups
too.6,7 Using a questionnaire based approach many large
studies have successfully employed this methodology to
gather data on mortality and SCD.8e103. Burden of SCD in the population
True incidence of SCD in the community is difficult to ascer-
tain in view of varied definitions andmethodologies employed
in different studies. The population included in each of these
studies is dissimilar, making generalized inferences difficult.
Further, in many of the studies the figures available are an
estimate rather than exact data obtained from a prospective
population based assessment. Table 1 highlights these facts
and gives a summary of data obtained from different parts of
the world. One of the earliest long-term systematic studies on
SCD was the Paris Prospective Study.3 The factors influencing
sudden death in a cohort of about 7000 middle aged working
male population followed up for 23 yearswere analyzed in this
study. SCD constituted 5.6% of total mortality and about 1/5th
of all the cardiovascular deaths. The analysis of the United
States vital statistics mortality data from 1989 to 1998 showed
that 63% of the 7 lakh cardiac deaths in the country were
sudden.11 This surveillance report from the US center for
disease control and prevention is the basis for the estimated
annual SCD figures of about 4.5e5 lakhs in the United States.studies conducted in various countries are summarized.
portion of total mortality.
Method of assessment SCD statistics
ed
ng
Death certificates 456,076 (63% of cardiac
deaths)
Multiple sources
ascertainment
53/100,000
Medical examination, blood
reports, hospital records,
death certificates
5.6% of total mortality
up
of
GPs, ambulance personnel,
and hospital records
97/100,000
in
ar
Multiple sources
ascertainment
51.5/100,000
n
2
Autopsy Prevalence in the four, 12
year periods was 4%, 6.2%,
8.6% and 9.7% respectively
Death certificates, hospital
records, Interview of
relatives and witnesses
41.8/100,000
d
Verbal autopsy 10% of total mortality
r
Mailed questionnaires and
direct interview of relatives
38/100,000
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) s 1 8es 2 3S20All deaths occurring out of hospital, in the emergency room or
“dead on arrival” associated with underlying heart diseases as
per ICD codes were presumed to be sudden without further
adjudication. The Maastricht study from the Netherlands
collected data from a defined geographical area having 1.3-
lakh inhabitants between ages 20 and 75 years.12 There were
515 witnessed and unwitnessed victims of sudden cardiac
arrest included in the period from 1991 to 1994 resulting in an
annual incidence of respectively 9.8e9.0/10,000 population.
The Oregon sudden unexpected death study is a compre-
hensive assessment of incidence of SCD obtained from the
Multnomah County with a population of 6 lakhs using multi-
ple sources of surveillance initially from 2002 to 2003 and
continued thereafter.13 Cases were identified by the first re-
sponders, medical examiner’s office and area hospitals. A
total of 353 cases met the criteria for SCD, based on the cir-
cumstances of death, hospital records and autopsy data,
whichwere available in 12% of the cases. This study found the
annual incidence of SCD to be 53 per 1 lakh residents consti-
tuting 5.6% of total mortality. Using the same methodology of
multiple source surveillance, a study of 4-lakh residents from
west of Ireland involving predominantly rural population in
the year 2005 recorded 212 cases of sudden cardiac arrest,
resulting in an incidence of 51.5/1-lakh population.5 This
study had an autopsy rate of 96.6%. Data from Asia has been
relatively sparse and the impact of SCD is being increasingly
perceived with the progressively increasing incidence of Cor-
onary Artery Disease (CAD). A study in the Okinawa island of
Japan showed that SCD constituted 10% of total deaths and
the crude incidence rate was 0.37/1000 population.2 The
Hisayama study was an autopsy-based study involving adult
population in a town in Japan from 1962 to 2009 illustrating
trends of Sudden Unexpected Deaths (SUD) over this period.
Deaths due to strokes, heart disease, aortic aneurysm and
dissectionwere included in this study. It showed that SUD and
deaths due to strokes declined over time but prevalence of
SCDdoubled from4% to 9.7% in the four, 12-year study periods
and this paralleled the increase in ischemic heart disease
during this time.14 A 3-level surveillance and case ascertain-
ment systemduring a period of 1 year in 4 regions ofmainland
China with a population of about 6 lakhs, found SCD preva-
lence to be 41.8/1 lakh population accounting for 9.5% of total
mortality. An autopsy series of 14,000 from across China
found that 12.5% of these deaths could be categorized as
sudden.15,16 India presents unique challenges in employing
conventional epidemiological tools to collect mortality data
and possibly due to these factors until recently there was no
contribution to global SCD data. Registration of deaths is not
universal and only a proportion of them are medically certi-
fied. Lack of uniform codes and inconsistent physician attri-
bution of causes contributes to the unreliability of death
certificates. The coverage of emergency services with first
responders is limited to select areas and they do not collect
data on out-of-hospital deaths. Autopsies are almost entirely
confined to medico legal cases conducted in government run
hospitals. To overcome these impediments, verbal autopsy
using questionnaires administered by trained health workers
was used to collect mortality data in 45 villages in the state of
Andhra Pradesh. Analysis of this data revealed that cardio-
vascular diseases were the leading causes of mortality in ruralpopulation. Though the questionnaires of this study were not
specifically designed to obtain SCD information, retrospec-
tively data was analyzed to estimate the prevalence of sudden
deaths in this rural population.17,18 The first data of SCD in
Indian population was obtained by applying the verbal au-
topsy methodology to medical students across the state of
Andhra Pradesh.19 In this study a 2-level questionnaire was
administered to the respondents with the objective of ascer-
taining the details of deaths in their kindreds. By using this
novel strategy, fairly reliable mortality data of a large general
population was obtained from about 500 medical students.
Each of these deaths was categorized by a 3 member adjudi-
cation system as SCD or otherwise. Of the 22,000 population
there were 1691 recallable deaths and finally 173 out of these
(10.3%)were adjudicated as SCD. Amajor difference compared
to the data from developed countries was that the SCD pop-
ulation was younger (mean age 60.8  14 years), with 21%
younger than 50 years. The study highlighted the fact that
unevaluated ischemic heart disease was the predominant
cause of SCD in the general population. It was found that in
the SCD cohort there was a large prevalence of coronary risk
factors without traditional risk factors known to be associated
with sudden death. Extrapolating the data to national mor-
tality figures, it can be roughly estimated that annually about
7-lakh SCD cases occur in India.4. SCD following Myocardial Infarction
SCD is a devastating clinical event, which is temporally
associated with MI throughout its natural and intervened
course. In the early phase, it is related to electrical instability
of the myocardium, recurrent ischemia and cardiac rupture
while in the later phases it is related tomyocardial remodeling
leading to macro reentrant VT. It has been observed that the
first month following MI is a period of increased vulnerability
to overall mortality and sudden death.20,21 It was demon-
strated in the DANAMI trial that half of all deaths and 63% of
cardiac deaths occurred in the first month following MI.
However the difficulty in adjudicating all sudden deaths as
arrhythmic was shown by the limited autopsy data of the
VALIANT trial where 12% of the presumed sudden deaths
were due to cardiac rupture.22
Over the years, there has been in general an improvement
in post-MI outcomes, which can be attributed to improved ICU
care, timely reperfusion, appropriate revascularization and
increased usage of evidence based medications. These mea-
sures have contributed to reduction in overall mortality and in
the incidence of sudden death, a fact which is evident not only
in the controlled clinical trials but also in the community
based studies. The Framinghamheart study is a followup data
of 333 patients predominantly with QMI, over a 17-year period
beginning 1968, when cardiac enzymes became available. The
first year incidence of SCD in this report was 3.6% while the
cumulative 5-year incidence was 7%.23 Subsequent studies,
where routine incorporation of evidence based modern ther-
apies was increasingly being practiced, documented a pro-
gressive decrement in these figures. CAMI was a 1 year follow
up study for 3178 patients admittedwithMI from 1990 to 92, in
nine Canadian hospitals where 1.9% of the mortality was due
Fig. 1 e The distribution of sudden deaths over 3 years in
the VALIANT and the Indian study are contrasted in this
figure. Most of the SCD in the Indian study occurred in the
first year. In the early period, the reduction in SCD is
achieved by reperfusion, revascularization and compliance
with medications. Beyond this period, use of defibrillators
in addition to medications has shown to decrease
incidence of SCD. The figure highlights the areas where
SCD prevention measures need to be focused in India.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) s 1 8es 2 3 S21to presumed arrhythmic death.24 A linear assessment of SCD
incidence in the MI population (n ¼ 3296) was conducted in
Olmsted county ofMinnesota from 1979 to 2005with amedian
follow up of 4.7 years.25 In this period the documented
reduction in SCD was 20% and 38% in the 2nd and 3rd octets
compared to the first 8 years of the study. This progressive
decline in SCD mortality was not just a part of decrease in
overall MI mortality but there was also a reduction in absolute
numbers as seen by the fact that SCD in this study constituted
20e30% of all deaths compared to about 50% in the previous
studies. The risk of SCD in the 30-day survivors post-MI
declined to 1.2%/year, which is lower than that expected in the
general population. A similar linear study from Japan over 14
years period from 1986 documented a progressive decrease in
the first year post MI SCD from 1.1% to 0.2%.26 These trends
emphatically demonstrate correlation of improved in-hospital
and post-discharge care of these patients with the reduction
inmortality. This fact was reiterated in a study conducted in 2
European centers where optimal evidence based therapy
achieved an annual SCD incidence of 0.4%. This study was
conducted in a closely supervised setting where 84% of the
patients were revascularized, 94% received beta blockers and
aspirin, 74% received ACE inhibitors and 64% received sta-
tins.27 Unfortunately data from India does not seem to reflect
these encouraging positive global trends in the outcomes of
MI. A comprehensive data on the acute coronary syndromes
in India was obtained by the CREATE registry which is a pro-
spective database of over 20,000 patients from 89 hospitals in
50 cities.28 This report gave the first insight into the epidemic
of CAD from this part of the globe. A striking difference
evident in this study was in the constitution of patient pop-
ulation where, in contrast to previous literature, it was shown
that about 60% of the patients with Acute Coronary Syndrome
(ACS) had STEMI. The patients were younger (mean age 57.5
years) and had delayed presentation to the hospital (mean
time of presentation¼ 6 h) after the clinical event. Only 58% of
STEMI patients received thrombolytic therapy and 8% had PCI.
By design the follow up was only for 30 days and the overall
mortality at that point was 9% in STEMI and 3.6% in NSTEMI
population. The study additionally revealed the significant
influence of socio economic factors on the treatment and
demonstrated a clear gradient of mortality across different
classes, with highest mortality in patients among lower socio
economic strata. The only focused report on the incidence of
SCD in post STEMI population in India is a single center study,
which collected data prospectively in 939 patients who were
followed up for a mean period of 41 months.29 This study
replicated the facts noted in the CREATE study that distin-
guished the STEMI population of India from those in the
published literature and they included younger age group,
lesser number of patients receiving reperfusion therapy, and
delayed presentation to hospital. This study further showed
that the cumulative incidence of SCD at 1 month, and first 3
years was 4.9%, 6.5%, 8%and 8.9% respectively. SCD consti-
tuted about 50% of mortality in hospital and throughout the
follow up period. Importantly, over half of all the SCD
occurred in the first month while about 3/4ths were seen in the
first year after the index STEMI. It follows that there is a rapid
attrition of ICD eligible patients as a significant number of SCD
occur even before these devices can be considered. Thispattern is in sharp contrast to the temporal profile of sudden
deaths observed in the VALIANT study where approximately
only 25% of SCD occurred in the first month while 65%
occurred after 90 days (Fig. 1).
In this study, the factors that were shown to predict SCD
by multivariate analysis were female gender, severe LV
Dysfunction, absence of reperfusion & revascularization and
poor adherence to medications. The issue of global variability
in adherence to evidence based medications in patients with
cardiovascular disease was addressed by the PURE study
which prospectively recruited about 1.5 lakh patients from 17
countries.30 This report highlighted the fact that proven evi-
dence based medications are globally underused and the
compliance to these medications is worse in low-income
countries. Patients with CAD of south Asian subset, which
included India revealed strikingly low usage of preventive
medications e beta-blockers 11.9%, Antiplatelets 11.6%, ACEI/
ARB 26.2% and statins 4.8%.5. Inferences and strategies for SCD
prevention
Many important facts emerge from the data available. Firstly
the issue of defining epidemiology of the problem of SCD is far
from complete as the global data is not universally repre-
sented. There is a need to design innovative strategies to ac-
quire data from underdeveloped areas of the world.31 As this
data is becoming available, it is clearly apparent that there
exists a wide geographical heterogeneity in the burden of SCD
and the factors influencing it. Secondly, the rising incidence of
clinical and sub clinical CAD in the developing countries
predicts the nurturing of a large population with a vulnerable
substrate for SCD and an explosion in SCD numbers. The
immediate focus in these communities should be on primary
and secondary prevention programs, wider reach of first
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) s 1 8es 2 3S22responders, timely management of ACS patients, and
compliance with evidence based medications. The decline in
the post MI mortality and SCD achieved in the developed
countries in the last few decades predates the routine usage of
ICD and can largely be attributed to adoption of these strate-
gies.32 Thirdly, a clearly visible distinction of the SCD cohort
from India compared to the western world is the predomi-
nance of economically productive younger population, which
is a matter of concern. Though intuitively this appears to
result as a consequence of increasing prevalence of CAD in the
young, it is prudent to investigate this problem further. It is
apparent that the issues affecting post-MI mortality are
neither uniformnor homogenous. Optimal implementation of
primary and secondary prevention measures in some parts of
the globe has resulted in decline in early post-MI mortality
and SCD. In these communities prescription of defibrillators
has further contributed to the reduction in the long-term
mortality. India and possibly other countries with similar
socio economic profile suffer from dual problems of a higher
incidence of early post MI mortality and paucity of resources
to fund ICDs. This warrants designing focused health care
policies and evolving specific cost effective strategies.Conflicts of interest
The author has none to declare.r e f e r e n c e s
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